These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Transplanted MHC class I-deficient nonobese diabetic mouse islets are protected from autoimmune injury in diabetic nonobese recipients. Prange S; Zucker P; Jevnikar AM; Singh B Transplantation; 2001 Apr; 71(7):982-5. PubMed ID: 11349735 [TBL] [Abstract][Full Text] [Related]
3. The role of autoimmunity in islet allograft destruction: major histocompatibility complex class II matching is necessary for autoimmune destruction of allogeneic islet transplants after T-cell costimulatory blockade. Makhlouf L; Kishimoto K; Smith RN; Abdi R; Koulmanda M; Winn HJ; Auchincloss H; Sayegh MH Diabetes; 2002 Nov; 51(11):3202-10. PubMed ID: 12401711 [TBL] [Abstract][Full Text] [Related]
4. A major role for host MHC class I antigen presentation for promoting islet allograft survival. Beilke J; Johnson Z; Kuhl N; Gill RG Transplant Proc; 2004 May; 36(4):1173-4. PubMed ID: 15194406 [TBL] [Abstract][Full Text] [Related]
5. "Indirect" acute islet allograft destruction in nonobese diabetic mice is independent of donor major histocompatibility complex and requires host B lymphocytes. Kupfer T; Beilke JN; Pham K; Buhrman J; Gill RG Transplant Proc; 2008 Mar; 40(2):462-3. PubMed ID: 18374102 [TBL] [Abstract][Full Text] [Related]
6. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice. Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475 [TBL] [Abstract][Full Text] [Related]
7. Use of donor beta 2-microglobulin-deficient transgenic mouse liver cells for isografts, allografts, and xenografts. Li X; Faustman D Transplantation; 1993 Apr; 55(4):940-6. PubMed ID: 8475570 [TBL] [Abstract][Full Text] [Related]
8. Recurrent autoimmunity accelerates destruction of minor and major histoincompatible islet grafts in nonobese diabetic (NOD) mice. Okitsu T; Bartlett ST; Hadley GA; Drachenberg CB; Farney AC Am J Transplant; 2001 Jul; 1(2):138-45. PubMed ID: 12099361 [TBL] [Abstract][Full Text] [Related]
10. Prolongation of in vivo mouse islet allograft survival by modulation of MHC class I antigen. Osorio RW; Ascher NL; Stock PG Transplantation; 1994 Mar; 57(6):783-8. PubMed ID: 8154021 [TBL] [Abstract][Full Text] [Related]
11. Allogeneic chimerism induces donor-specific tolerance to simultaneous islet allografts in nonobese diabetic mice. Li H; Kaufman CL; Ildstad ST Surgery; 1995 Aug; 118(2):192-7; discussion 197-8. PubMed ID: 7638733 [TBL] [Abstract][Full Text] [Related]
12. Prolonged survival of class I deficient mouse islet allografts but not xenografts. Markmann JF; Desai NM; Bassiri H; Kim JI; Barker CF Transplant Proc; 1994 Apr; 26(2):748. PubMed ID: 8171641 [No Abstract] [Full Text] [Related]
14. Differences in suppressor of cytokine signaling-1 (SOCS-1) expressing islet allograft destruction in normal BALB/c and spontaneously-diabetic NOD recipient mice. Solomon M; Flodström-Tullberg M; Sarvetnick N Transplantation; 2005 May; 79(9):1104-9. PubMed ID: 15880051 [TBL] [Abstract][Full Text] [Related]
15. The degree of phylogenetic disparity of islet grafts dictates the reliance on indirect CD4 T-cell antigen recognition for rejection. Rayat GR; Johnson ZA; Beilke JN; Korbutt GS; Rajotte RV; Gill RG Diabetes; 2003 Jun; 52(6):1433-40. PubMed ID: 12765954 [TBL] [Abstract][Full Text] [Related]
16. MHC-mismatched chimerism is required for induction of transplantation tolerance in autoimmune nonobese diabetic recipients. Wang M; Racine J; Zhang M; Wu T; Deng R; Johnston H; Shen C; Siswanto K; Zeng D J Immunol; 2014 Aug; 193(4):2005-15. PubMed ID: 25000982 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the role of major histocompatibility complex in type 1 diabetes recurrence after islet transplantation. Young HY; Zucker P; Flavell RA; Jevnikar AM; Singh B Transplantation; 2004 Aug; 78(4):509-15. PubMed ID: 15446308 [TBL] [Abstract][Full Text] [Related]
18. Role of intra-islet endothelial cells in islet allo-immunity. Bharat A; Saini D; Benshoff N; Goodman J; Desai NM; Chapman WC; Mohanakumar T Transplantation; 2007 Nov; 84(10):1316-23. PubMed ID: 18049117 [TBL] [Abstract][Full Text] [Related]
19. Major histocompatibility complex class I deficiency prolongs islet allograft survival. Osorio RW; Ascher NL; Jaenisch R; Freise CE; Roberts JP; Stock PG Diabetes; 1993 Oct; 42(10):1520-7. PubMed ID: 8375593 [TBL] [Abstract][Full Text] [Related]